DOSAGE FORM INDEX - OBJECTIVE CRITERION FOR EVALUATION OF CONTROLLED-RELEASE DRUG DELIVERY SYSTEMS

被引:23
作者
THEEUWES, F [1 ]
BAYNE, W [1 ]
机构
[1] ALZA CORP,PALO ALTO,CA 94304
关键词
D O I
10.1002/jps.2600661009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1388 / 1392
页数:5
相关论文
共 12 条
[1]   ASSAY FOR ACETAZOLAMIDE IN PLASMA [J].
BAYNE, WF ;
ROGERS, G ;
CRISOLOGO, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (03) :402-404
[2]  
DOST-ASTI, 2020, PHILS
[3]   ADVANTAGES OF SUSTAINED-RELEASE THERAPY WITH ACETAZOLAMIDE IN GLAUCOMA [J].
GARNER, LL ;
FERWERDA, JR ;
CARL, EF .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1963, 55 (02) :323-&
[4]  
KRUGERTHIEMER E, 1965, PHYSICO CHEMICAL ASP, V7, P63
[5]  
LEHMANN B, 1969, ADV BIOSCI, V5, P197
[6]   ELEMENTARY OSMOTIC PUMP [J].
THEEUWES, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (12) :1987-1991
[7]  
WAGNER JG, 1975, FUNDAMENTALS CLINICA
[8]  
Wagner JG, 1971, BIOPHARMACEUTICS REL
[9]  
WALLACE SM, 1975, ABSTR APHA AC PHARM, P137
[10]  
ZAFFARONI A, 1971, 31ST INT C PHARM SCI, P19